Status: Recruiting
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
An open label study to investigate the safety and efficacy of ponesimod in participants with moderate-to-severe chronic plaque psoriasis
Participants needed: 300
Trial details
Phase: Phase 3Age: 18-65Biological sex: AllType: InterventionalSponsor: Vanda PharmaceuticalsUpdated: Jun 11, 2026Locations: 4
Eligibility criteria
Male and female subjects aged 18-65 years, inclusive [+5]
Diagnosis of generalized erythrodermic, generalized pustular (von Zumbusch), gut... [+1]